What is HYPR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.10B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HYPR?

P/E (TTM) is n/a and 52-week range is $0.75 to $2.22 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HYPR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HYPR?

The company profile lists revenue (TTM) near $16M, net income (TTM) near $-3.47B, EPS (TTM) near $-0.38 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Hyperfine Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Guilford, Connecticut, US, 99.3M shares outstanding, ISIN US44916K1060 when available from company profile and filing metadata.

Hyperfine Inc

$HYPR

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$0.93

-1.00%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 102 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

Employees

102

Website

hyperfinemri.com/

IPO

2021-01-27

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)